← Leaderboards
Jack Henkin
Pamdeca, Llc
$596,582
Attributed
$596,582
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $299.8K · FY2018–22$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$596,582 · 2
By mechanism
R43$596,582 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Safety”
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
- Kimberly Smith · Ppd Development Lp$122,008,792
- Klaus Romero · Critical Path Institute$90,404,592
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$75,904,237
- Yunda Huang · Fred Hutchinson Cancer Center$70,809,823
- Leonard Freedman · Leidos Biomedical Research, Inc.$64,938,611
Research focus
SafetyClinical ResearchPreventTreatment EfficacyInflammatoryCellsDosePre-ClinicalSmall Business Innovation Research GrantBaseProteinsMouse ModelAngiogenesis InhibitorsAngiogenesis InhibitionAerosolsAngiogenesisAmino AcidsAdverse EffectsAcuteAqueousAlveolar Type Ii CellAntibodiesBehaviorAnimal Model